MRK

Merck (MRK)

Merck and Co Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:MRK
DateTimeSourceHeadlineSymbolCompany
09/19/20217:30AMBusiness WireMerck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Reduced Risk of Death by 27% Versus Chemotherapy as First-Line Treatment for Patients With Metastatic Triple-Negative Breast Cancer Whose Tumors Expressed PD-L1 (CPS ≥10) NYSE:MRKMerck and Co Inc
09/18/20219:05AMBusiness WireMerck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Death by One-Third Versus Chemotherapy With or Without Bevacizumab as First-Line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer NYSE:MRKMerck and Co Inc
09/18/20219:05AMBusiness WireMerck’s KEYTRUDA® (pembrolizumab) Demonstrated Superior Recurrence-Free Survival (RFS) in Patients With Resected High-Risk Stage II Melanoma Compared to Placebo in the Adjuvant Setting NYSE:MRKMerck and Co Inc
09/17/202110:00PMDow Jones NewsPreview -- Barron's NYSE:MRKMerck and Co Inc
09/17/20218:04AMDow Jones NewsMerck Gets CHMP Backing of Keytruda in Triple-Negative Breast Cancer NYSE:MRKMerck and Co Inc
09/17/20217:15AMBusiness WireMerck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy for Certain Patients With Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1 (CPS ≥10) NYSE:MRKMerck and Co Inc
09/15/20215:20PMSeeking AlphaHouse committee approves portion of spending package that includes drug price negotiation NYSE:MRKMerck and Co Inc
09/15/20214:23PMSeeking AlphaNarrower drug pricing bill introduced in House by centrist Democrats NYSE:MRKMerck and Co Inc
09/15/20218:29AMSeeking AlphaOral version of Gilead's remdesivir demonstrates promising preclinical results NYSE:MRKMerck and Co Inc
09/15/20218:17AMDow Jones NewsHookipa Working With Merck in Advanced Head and Neck Cancers NYSE:MRKMerck and Co Inc
09/14/20218:45AMNetworkNewsWireHypertension: The Silent Killer Making Loud Noise for Investors NYSE:MRKMerck and Co Inc
09/09/20214:26PMSeeking AlphaCodexis and Merck extend supply agreement for enzyme used in manufacture of sitagliptin NYSE:MRKMerck and Co Inc
09/08/20216:45AMBusiness WireMerck To Present New Data From Its Broad Oncology Portfolio and Pipeline at ESMO 2021, Including in Earlier Stages of Cancer NYSE:MRKMerck and Co Inc
09/07/20216:45AMBusiness WireMerck to Present at the Morgan Stanley 19th Annual Healthcare Conference NYSE:MRKMerck and Co Inc
09/07/20216:45AMBusiness WireMerck’s KEYTRUDA® (pembrolizumab) Approved in China in Combination With Chemotherapy for First-Line Treatment of Patients With Locally Advanced Unresectable or Metastatic Esophageal or Gastroesophageal Junction (GEJ) Carcinoma NYSE:MRKMerck and Co Inc
09/01/20217:30AMDow Jones NewsMerck, Ridgeback Launch Phase 3 Trial of Covid-19 Prophylactic NYSE:MRKMerck and Co Inc
09/01/20216:45AMBusiness WireMerck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD Study Evaluating Molnupiravir for Post-Exposure Prophylaxis of COVID-19 Infection NYSE:MRKMerck and Co Inc
08/31/20214:05PMBusiness WireFDA Approves Updated Indication for Merck’s KEYTRUDA® (pembrolizumab) for Treatment of Certain Patients With Urothelial Carcinoma (Bladder Cancer) NYSE:MRKMerck and Co Inc
08/26/20216:45AMBusiness WireMerck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan NYSE:MRKMerck and Co Inc
08/25/202110:47AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3) NYSE:MRKMerck and Co Inc
08/25/20218:00AMDow Jones NewsMerck's Vaxneuvance Hits Key Endpoints in Infant Study NYSE:MRKMerck and Co Inc
08/25/20216:45AMBusiness WireMerck Announces VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) Met Key Immunogenicity and Safety Endpoints in Phase 3 Pivotal Trial Evaluating Use in Infants, PNEU-PED (V114-029) NYSE:MRKMerck and Co Inc
08/23/202111:13AMSeeking AlphaAgilent companion diagnostic expands CE-IVD mark in Europe to include esophageal cancer NYSE:MRKMerck and Co Inc
08/20/20214:56PMEdgar (US Regulatory)Current Report Filing (8-k) NYSE:MRKMerck and Co Inc
08/20/20214:45PMBusiness WireLeslie A. Brun Resigns from Merck Board of Directors NYSE:MRKMerck and Co Inc
08/19/202110:14PMSeeking AlphaActing FDA head Woodcock ruled out as permanent nominee - Bloomberg NYSE:MRKMerck and Co Inc
08/18/20218:45AMDow Jones NewsWerewolf to Study WTX-124 With Merck's Keytruda in Solid Tumors NYSE:MRKMerck and Co Inc
08/18/20217:44AMSeeking AlphaWerewolf Therapeutics teams up with Merck for WTX-124/Keytruda combo cancer study NYSE:MRKMerck and Co Inc
08/13/20217:00PMBusiness WireFDA Approves Merck’s Hypoxia-Inducible Factor-2 Alpha (HIF-2α) Inhibitor WELIREG™ (belzutifan) for the Treatment of Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors NYSE:MRKMerck and Co Inc
08/13/20216:41PMPR Newswire (Canada)Merck Canada entreprend des démarches auprès de Santé Canada en vue de l'examen continu du molnupiravir, un agent thérapeutique oral expérimental pour le traitement de la COVID-19 NYSE:MRKMerck and Co Inc
 Showing the most relevant articles for your search:NYSE:MRK
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20210920 07:36:41